Advertisement

Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner

  • Karen F.S. Bell
  • A. Claudio Cuello
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)

Keywords

Mild Cognitive Impairment Amyloid Precursor Protein Cholinergic System Plaque Size Amyloid Pathology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Morris JC, Cole M, Banker BQ, Wright D. Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 1984;16:455–466.PubMedCrossRefGoogle Scholar
  2. 2.
    Geula C, Mesulam MM, Saroff DM, Wu CK. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:63–75.PubMedGoogle Scholar
  3. 3.
    Henderson Z. Responses of basal forebrain cholinergic neurons to damage in the adult brain. Prog Neurobiol 1996;48:219–254.PubMedCrossRefGoogle Scholar
  4. 4.
    Hyman BT, Van Horsen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168–1170.PubMedCrossRefGoogle Scholar
  5. 5.
    Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 1990;37:377–385.PubMedCrossRefGoogle Scholar
  6. 6.
    Pearson RC, Esiri MM, Hiorns RW, et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A 1985;82:4531–4534.PubMedCrossRefGoogle Scholar
  7. 7.
    Rogers J, Morrison JH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 1985;5:2801–2808.PubMedGoogle Scholar
  8. 8.
    Saper C, German D, White C. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer type: possible role in cell loss. Neurology 1985;35:1089–1095.PubMedGoogle Scholar
  9. 9.
    Bowen DM, Smith CD. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976;99:459–496.PubMedCrossRefGoogle Scholar
  10. 10.
    Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2(8000):1403.PubMedCrossRefGoogle Scholar
  11. 11.
    DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990;27:457–464.PubMedCrossRefGoogle Scholar
  12. 12.
    Masliah E, Terry RD, Mallory M, et al. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 1990;137:1293–1297.PubMedGoogle Scholar
  13. 13.
    Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572–580.PubMedCrossRefGoogle Scholar
  14. 14.
    Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996;274:99–102.PubMedCrossRefGoogle Scholar
  15. 15.
    Duff K, Eckman C, Zehr C, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996;383:710–713.PubMedCrossRefGoogle Scholar
  16. 16.
    Holcomb L, Gordon MN, McGowan E, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998;4:97–100.PubMedCrossRefGoogle Scholar
  17. 17.
    Wong TP, Debeir D, Duff, Cuello AC. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci 1999;19:2706–2716.PubMedGoogle Scholar
  18. 18.
    Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 1997;94:13287–13292.PubMedCrossRefGoogle Scholar
  19. 19.
    Boncristiano S, Calhoun ME, Kelly PH, et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 2002;22:3234–3243.PubMedGoogle Scholar
  20. 20.
    Gau JT, Steinhilb ML, Kao TC, et al. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. Am J Pathol 2002;160:731–738.PubMedGoogle Scholar
  21. 21.
    Hernandez S, Sugaya K, Qu T, et al. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes, Neuroreport 2001;12:1377–1384.PubMedCrossRefGoogle Scholar
  22. 22.
    Jaffar S, Counts SE, Ma SY, et al. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Exp Neurol 2001;170:227–243.PubMedCrossRefGoogle Scholar
  23. 23.
    Masliah E, Rockenstein E, Veinbergs I, et al. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A 2001;98:12245–12250.PubMedCrossRefGoogle Scholar
  24. 24.
    Price DL, Koliatsos VE, Clatterbuck RC. Cholinergic systems: human diseases, animal models and prospects for therapy. Prog Brain Res 1993;98:51–60.PubMedGoogle Scholar
  25. 25.
    DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145–155.PubMedCrossRefGoogle Scholar
  26. 26.
    Ikonomovic MD, Mufson EJ, Wuu J, et al. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis 200;35:39–48.Google Scholar
  27. 27.
    Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.PubMedCrossRefGoogle Scholar
  28. 28.
    Kar S, Seto D, Gaudreau P, Quirion R. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J Neurosci 1996;16:1034–1040.PubMedGoogle Scholar
  29. 29.
    Mattson MP, Cheng B, Culwell AR, et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993;10:243–254.PubMedCrossRefGoogle Scholar
  30. 30.
    Mattson MP. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 1994;25:439–450.PubMedCrossRefGoogle Scholar
  31. 31.
    Furukawa K, Sopher BL, Rydel RE, et al. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 1996;67:1882–1896.PubMedCrossRefGoogle Scholar
  32. 32.
    Small DH, Nurcombe V, Reed G, et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 1994;14:2117–2127.PubMedGoogle Scholar
  33. 33.
    Postina R, Schroeder A, Dewachter I, et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004;113:1456–1464.PubMedCrossRefGoogle Scholar
  34. 34.
    Buxbaum JD, Liu KN, Luo Y, et al. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 1998;273:27765–27767.PubMedCrossRefGoogle Scholar
  35. 35.
    Esch FS, Keim PS, Beattie EC, et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 1990;248:1122–1124.PubMedCrossRefGoogle Scholar
  36. 36.
    Haass C, Koo EH, Mellon A, et al. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992;357:500–503.PubMedCrossRefGoogle Scholar
  37. 37.
    Koike H, Tomioka S, Sorimachi H, et al. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J 1999;343(Pt 2):371–375.PubMedCrossRefGoogle Scholar
  38. 38.
    Kojro E, Gimpl G, Lammich S, et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A 2001;98:5815–5820.PubMedCrossRefGoogle Scholar
  39. 39.
    Lammich S, Kojro E, Postina R, et al. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 1999;96:3922–3927.PubMedCrossRefGoogle Scholar
  40. 40.
    Marcinkiewicz M, Seidah NG. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 2000;75:2133–2143.PubMedCrossRefGoogle Scholar
  41. 41.
    Sisodia SS. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A 1992;89:6075–6079.PubMedCrossRefGoogle Scholar
  42. 42.
    Kojro E, Fahrenholz F. The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem 2005;38:105–127.PubMedCrossRefGoogle Scholar
  43. 43.
    Moechars D, Dewachter I, Lorent K, et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999;274:6483–6492.PubMedCrossRefGoogle Scholar
  44. 44.
    Sennvik K, Fastbom J, Blomberg M, et al. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 2000;278:169–172.PubMedCrossRefGoogle Scholar
  45. 45.
    Lannfelt L, Basun H, Wahlund LO, et al. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med 1995;1:829–832.PubMedCrossRefGoogle Scholar
  46. 46.
    Hu L, Wong TP, Cote SL, et al. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in Alzheimer's disease-like transgenic mice. Neuroscience 2003;121:421–432.PubMedCrossRefGoogle Scholar
  47. 47.
    Chishti MA, Yang DS, Janus C, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001;276:21562–21570.PubMedCrossRefGoogle Scholar
  48. 48.
    Bell KF, de Kort GJ, Steggerda S, et al. Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci Lett 2003;353:143–147.PubMedCrossRefGoogle Scholar
  49. 49.
    Bell KFS, Ducatenzeiler A, Ribeiro-da-Silva A, et al. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 2006;27:1644–1657.PubMedCrossRefGoogle Scholar
  50. 50.
    Bell KFS, Ribeiro-da-Silva A, Cuello AC. Evidence of a neurotransmitter-specific attrition in the Alzheimer's disease like pathology, 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy, 8L, 40 (2004).Google Scholar
  51. 51.
    Cuello AC, Bell KFS, Ribeiro-da-Silva A. Amyloid formation provokes transmitter-specific changes and dystrophic neurite formation in the absence of neurofibrillary pathology. Neurobiol Aging 2004;25:S1-S30.CrossRefGoogle Scholar
  52. 52.
    Casu MA, Wong TP, De Koninck Y, et al. Aging causes a preferential loss of cholinergic innervation of characterized neocortical pyramidal neurons. Cereb Cortex 2002;12:329–337.PubMedCrossRefGoogle Scholar
  53. 53.
    Bell KFS,Ribeiro-da-Silva A, Duff K, Cuello AC. A sequential and neurotransmitter-specific involvement of dystrophic neurites in the amyloid pathology. Neurobiol Aging 2004;25(2):S169..CrossRefGoogle Scholar
  54. 54.
    Bell KFS, Bennett DA, Cuello AC Amyloid plaque dependent glutamatergic neuritic dystrophy in the Alzheimer's disease brain. Presented at the 7th International AD/PD Conference, 2005.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Karen F.S. Bell
    • 1
  • A. Claudio Cuello
  1. 1.Department of Pharmacology and TherapeuticsMcGill UniversityMontrealCanada

Personalised recommendations